Beneficial bacteria stimulate host immune cells to counteract dietary and genetic predisposition to mammary cancer in mice

International Journal of Cancer

Volumn 135, Issue 3, 2014, Pages 529-540

  Lakritz, Jessica R ^a   Poutahidis, Theofilos ^a   Levkovich, Tatiana ^a   Varian, Bernard J ^a   Ibrahim, Yassin M ^a   Chatzigiagkos, Antonis ^b   Mirabal, Sheyla ^a   Alm, Eric J ^c,d   Erdman, Susan E ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c USA   (United States)

^d BROAD INSTITUTE OF MIT AND HARVARD   (United States)

Author keywords

Bacteria, inflammation; L. reuteri; Mammary cancer; Probiotics

Indexed keywords

PROBIOTIC AGENT;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BACTERIAL STRAIN; BREAST CANCER; BREAST CARCINOGENESIS; CANCER PREVENTION; CD4+ CD25+ T LYMPHOCYTE; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; GENETIC PREDISPOSITION; IMMUNOCOMPETENT CELL; IMMUNOSTIMULATION; LACTOBACILLUS REUTERI; LYMPHOCYTE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

BACTERIA, INFLAMMATION; L. REUTERI; MAMMARY CANCER; PROBIOTICS;

ANIMALS; APOPTOSIS; CD4-POSITIVE T-LYMPHOCYTES; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; LACTOBACILLUS REUTERI; MAMMARY NEOPLASMS, ANIMAL; MAST CELLS; MICE; MICE, TRANSGENIC; PROBIOTICS;

EID: 84901014117     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28702     Document Type: Article

References (50)

1. Boyle P, Levin B,. International agency for research on cancer, world health organization. World cancer report 2008. Lyon, Geneva: International Agency for Research on Cancer, WHO Press, 2008. 510 p.
2. Calle EE, Kaaks R,. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004; 4: 579-91.
3. Bhardwaj P, Du B, Zhou XK, et al. Caloric restriction reverses obesity-induced mammary gland inflammation in mice. Cancer Prev Res (Phila) 2013; 6: 282-9.
4. Ho VW, Leung K, Hsu A, et al. A low carbohydrate, high protein diet slows tumor growth and prevents cancer initiation. Cancer Res 2011; 71: 4484-93.
5. Cleary MP, Grossmann ME, Ray A,. Effect of obesity on breast cancer development. Vet Pathol 2010; 47: 202-13.
6. Khalid S, Hwang D, Babichev Y, et al. Evidence for a tumor promoting effect of high-fat diet independent of insulin resistance in HER2/Neu mammary carcinogenesis. Breast Cancer Res Treat 2010; 122: 647-59.
7. Gu JW, Young E, Patterson SG, et al. Postmenopausal obesity promotes tumor angiogenesis and breast cancer progression in mice. Cancer Biol Ther 2011; 11: 910-7.
8. Nunez NP, Perkins SN, Smith NC, et al. Obesity accelerates mouse mammary tumor growth in the absence of ovarian hormones. Nutr Cancer 2008; 60: 534-41.
9. Subbaramaiah K, Howe LR, Bhardwaj P, et al. Obesity is associated with inflammation and elevated aromatase expression in the mouse mammary gland. Cancer Prev Res (Phila) 2011; 4: 329-46.
10. Berryhill GE, Gloviczki JM, Trott JF, et al. Diet-induced metabolic change induces estrogen-independent allometric mammary growth. Proc Natl Acad Sci USA 2012; 109: 16294-9.
11. Hursting SD,. Inflammatory talk: linking obesity, NF-kappaB, and aromatase. Cancer Prev Res (Phila) 2011; 4: 285-7.
12. Rao VP, Poutahidis T, Ge Z, et al. Innate immune inflammatory response against enteric bacteria Helicobacter hepaticus induces mammary adenocarcinoma in mice. Cancer Res 2006; 66: 7395-400.
13. Rao VP, Poutahidis T, Fox JG, et al. Breast cancer: should gastrointestinal bacteria be on our radar screen? Cancer Res 2007; 67: 847-50.
14. Erdman SE, Rao VP, Olipitz W, et al. Unifying roles for regulatory T cells and inflammation in cancer. Int J Cancer 2010; 126: 1651-65.
15. Ursini-Siegel J, Schade B, Cardiff RD, et al. Insights from transgenic mouse models of ERBB2-induced breast cancer. Nat Rev Cancer 2007; 7: 389-97.
16. West NR, Kost SE, Martin SD, et al. Tumour-infiltrating FOXP3(+) lymphocytes are associated with cytotoxic immune responses and good clinical outcome in oestrogen receptor-negative breast cancer. Br J Cancer 2013; 108: 155-62.
17. Levkovich T, Poutahidis T, Smillie C, et al. Probiotic bacteria induce a 'glow of health'. PLoS One 2013; 8: e53867.
18. Poutahidis T, Kleinewietfeld M, Smillie C, et al. Microbial reprogramming inhibits western diet-associated obesity. PLoS One 2013; 8: e68596.
19. Smits HH, Engering A, van der Kleij D, et al. Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. J Allergy Clin Immunol 2005; 115: 1260-7.
20. Karimi K, Inman MD, Bienenstock J, et al. Lactobacillus reuteri-induced regulatory T cells protect against an allergic airway response in mice. Am J Respir Crit Care Med 2009; 179: 186-93.
21. Liu Y, Fatheree NY, Dingle BM, et al. Lactobacillus reuteri DSM 17938 changes the frequency of Foxp3(+) regulatory T cells in the intestine and mesenteric lymph node in experimental necrotizing enterocolitis. PLoS One 2013; 8: e56547.
22. van't Veer P, Dekker JM, Lamers JW, et al. Consumption of fermented milk products and breast cancer: a case-control study in The Netherlands. Cancer Res 1989; 49: 4020-3.
23. Chagas CE, Rogero MM, Martini LA,. Evaluating the links between intake of milk/dairy products and cancer. Nutr Rev 2012; 70: 294-300.
24. de Moreno, de LeBlanc A, Matar C, Perdigon G,. The application of probiotics in cancer. Br J Nutr 2007; 98 (Suppl 1): S105-S10.
25. de Moreno, de Leblanc A, Matar C, Farnworth E, et al. Study of immune cells involved in the antitumor effect of kefir in a murine breast cancer model. J Dairy Sci 2007; 90: 1920-8.
26. Maroof H, Hassan ZM, Mobarez AM, et al. Lactobacillus acidophilus could modulate the immune response against breast cancer in murine model. J Clin Immunol 2012; 32: 1353-9.
27. Saulnier DM, Santos F, Roos S, et al. Exploring metabolic pathway reconstruction and genome-wide expression profiling in Lactobacillus reuteri to define functional probiotic features. PLoS One 2011; 6: e18783.
28. Dommels YEM, Kemperman RA, Zebregs YEMP, et al. Survival of Lactobacillus reuteri DSM 17938 and Lactobacillus rhamnosus GG in the human gastrointestinal tract with daily consumption of a low-fat probiotic spread. Appl Environ Microbiol 2009; 75: 6198-204.
29. Wing K, Sakaguchi S,. Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat Immunol 2010; 11: 7-13.
30. Rao VP, Poutahidis T, Ge Z, et al. Proinflammatory CD4+ CD45RB(hi) lymphocytes promote mammary and intestinal carcinogenesis in Apc(Min/+) mice. Cancer Res 2006; 66: 57-61.
31. Nieto AI, Shyamala G, Galvez JJ, et al. Persistent mammary hyperplasia in FVB/N mice. Comp Med 2003; 53: 433-8.
32. Raafat A, Strizzi L, Lashin K, et al. Effects of age and parity on mammary gland lesions and progenitor cells in the FVB/N-RC mice. PLoS One 2012; 7: e43624.
33. Coussens LM, Pollard JW,. Leukocytes in mammary development and cancer. Cold Spring Harb Perspect Biol 2011; 3, pii: a003285.
34. DeNardo DG, Coussens LM,. Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression. Breast Cancer Res 2007; 9: 212.
35. Hanahan D, Coussens LM,. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell 2012; 21: 309-22.
36. Rook GA, Dalgleish A,. Infection, immunoregulation, and cancer. Immunol Rev 2011; 240: 141-59.
37. Erdman SE, Sohn JJ, Rao VP, et al. CD4+CD25+ regulatory lymphocytes induce regression of intestinal tumors in ApcMin/+ mice. Cancer Res 2005; 65: 3998-4004.
38. Litonjua AA, Weiss ST,. Is vitamin D deficiency to blame for the asthma epidemic? J Allergy Clin Immunol 2007; 120: 1031-5.
39. Harris DM, Go VL,. Vitamin D and colon carcinogenesis. J Nutr 2004; 134: 3463S-71S.
40. Shostak K, Chariot A,. NF-kappaB, stem cells and breast cancer: the links get stronger. Breast Cancer Res 2011; 13: 214.
41. Vleugel MM, Greijer AE, Bos R, et al. c-Jun activation is associated with proliferation and angiogenesis in invasive breast cancer. Hum Pathol 2006; 37: 668-74.
42. Jiao X, Katiyar S, Willmarth NE, et al. c-Jun induces mammary epithelial cellular invasion and breast cancer stem cell expansion. J Biol Chem 2010; 285: 8218-26.
43. Katiyar S, Casimiro MC, Dettin L, et al. C-jun inhibits mammary apoptosis in vivo. Mol Biol Cell 2010; 21: 4264-74.
44. Poutahidis T, Kearney SM, Levkovich T, et al. Microbial symbionts accelerate wound healing via the neuropeptide hormone oxytocin. PLoS One 2013; 8: e78898.
45. Dvorak HF,. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 1986; 315: 1650-9.
46. Maccio A, Madeddu C, Chessa P, et al. Oxytocin both increases proliferative response of peripheral blood lymphomonocytes to phytohemagglutinin and reverses immunosuppressive estrogen activity. In Vivo 2010; 24: 157-63.
47. Murrell TG,. The potential for oxytocin (OT) to prevent breast cancer: a hypothesis. Breast Cancer Res Treat 1995; 35: 225-9.
48. Barnard A, Layton D, Hince M, et al. Impact of the neuroendocrine system on thymus and bone marrow function. Neuroimmunomodulation 2008; 15: 7-18.
49. Hooper LV, Littman DR, Macpherson AJ,. Interactions between the microbiota and the immune system. Science 2012; 336: 1268-73.
50. Round JL, Mazmanian SK,. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci USA 2010; 107: 12204-9.